Women who take nonselective beta-blockers at the time of ovarian cancer surgery can result in greater two-year survival. Electronic patient-reported outcome follow-up for ovarian cancer was feasible, but only acceptable to certain patients. A specific type of ovarian cancer may benefit from existing platinum-based chemotherapy and DNA repairing treatments. Fatigue is a common and distressing symptom for patients with gynecologic cancers. Women with symptoms of posttraumatic stress disorder (PTSD) are at a higher risk of developing ovarian cancer, according to ...